So Merck (our supposed partner) has now invested billions in not one, but 2 other companies for ADCs after spending years looking at Starpharma’s ADCs ….. looking like they just aren’t interested in our ADCs but hey everyone is now cheering about the fact that we are going back to the drawing board with Medicxi ?
If the Starpharma science is as good as many continuously claim on here, why is our partner Merck always buying / investing elsewhere ? Why won’t they do a deal with Starpharma after their years of research ?
https://endpts.com/merck-buys-abceutics-to-make-adcs-safer/
Merck signs small acquisition to make ADCs safer
https://www.fiercebiotech.com/biote...-3-daiichi-adcs-huge-bet-post-keytruda-future
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
- Forums
- ASX - By Stock
- SPL
- Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-58
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.1¢ |
Change
0.001(1.11%) |
Mkt cap ! $37.49M |
Open | High | Low | Value | Volume |
9.1¢ | 9.3¢ | 8.9¢ | $196.0K | 2.178M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 164414 | 9.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 15150 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 164414 | 0.091 |
2 | 29795 | 0.090 |
2 | 117500 | 0.089 |
2 | 150000 | 0.088 |
1 | 11639 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 15150 | 1 |
0.096 | 30000 | 2 |
0.100 | 73848 | 3 |
0.105 | 375912 | 5 |
0.110 | 45099 | 6 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online